Hormone Replacement Therapy Market to Grow at a Moderate Rate at a CAGR of over 2% to 2019
The global hormone replacement therapy market is expected to witness some trends during the forecast period, which would be major influencers for market dynamics. One such trend is the paradigm shift toward non-hormonal therapies such as clonidine, venlafaxine, fluoxetine, and gabapentin to reduce symptoms of menopause, which is a paradigm shift from hormone-based therapies.
View full press release